Although many self-reactive T cells are eliminated by negative selection in the thymus, some of these cells escape into the periphery, where they must be controlled by additional mechanisms. However, the molecular mechanisms underlying peripheral T cell tolerance and its maintenance remain largely undefined. In this study, we report that sirtuin 1 (Sirt1), a type III histone deacetylase, negatively regulates T cell activation and plays a major role in clonal T cell anergy in mice. In vivo, we found that loss of Sirt1 function resulted in abnormally increased T cell activation and a breakdown of CD4+ T cell tolerance. Conversely, upregulation of Sirt1 expression led to T cell anergy, in which the activity of the transcription factor AP-1 was substantially diminished. Furthermore, Sirt1 interacted with and deacetylated c-Jun, yielding an inactive AP-1 factor. In addition, Sirt1-deficient mice were unable to maintain T cell tolerance and developed severe experimental allergic encephalomyelitis as well as spontaneous autoimmunity. These findings provide insight into the molecular mechanisms of T cell activation and anergy, and we suggest that activators of Sirt1 may be useful as therapeutic agents for the treatment and/or prevention of autoimmune diseases.
Jinping Zhang, Sang-Myeong Lee, Stephen Shannon, Beixue Gao, Weimin Chen, An Chen, Rohit Divekar, Michael W. McBurney, Helen Braley-Mullen, Habib Zaghouani, Deyu Fang
Title and authors | Publication | Year |
---|---|---|
Epigenetic enzymes are the therapeutic targets for CD4+CD25+/highFoxp3+ regulatory T cells
JL Pastrana, Y Shao, V Chernaya, H Wang, XF Yang |
Translational Research | 2014 |
Myeloid deletion of SIRT1 aggravates serum transfer arthritis in mice via nuclear factor-κB activation
YS Hah, YH Cheon, HS Lim, HY Cho, BH Park, SO Ka, YR Lee, DW Jeong, HO Kim, MK Han, SI Lee |
PloS one | 2014 |
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut
R Caruso, I Marafini, E Franzè, C Stolfi, F Zorzi, I Monteleone, F Caprioli, A Colantoni, M Sarra, S Sedda, L Biancone, P Sileri, GS Sica, TT MacDonald, F Pallone, G Monteleone |
Mucosal Immunology | 2014 |
DBC1 Is a Suppressor of B Cell Activation by Negatively Regulating Alternative NF- B Transcriptional Activity
S Kong, M Thiruppathi, Q Qiu, Z Lin, H Dong, EN Chini, BS Prabhakar, D Fang |
Journal of immunology (Baltimore, Md. : 1950) | 2014 |
A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis
Y Miyazaki, R Li, A Rezk, H Misirliyan, C Moore, N Farooqi, M Solis, LG Goiry, O Faria, VD Dang, D Colman, AS Dhaunchak, J Antel, J Gommerman, A Prat, S Fillatreau, A Bar-Or, |
PloS one | 2014 |
SIRT1 promoter polymorphisms as clinical modifiers on systemic lupus erythematosus
CR Consiglio, SJ da Silveira, OA Monticielo, RM Xavier, JC Brenol, JA Chies |
Molecular Biology Reports | 2014 |
PPARγ Negatively Regulates T Cell Activation to Prevent Follicular Helper T Cells and Germinal Center Formation
HJ Park, DH Kim, JY Choi, WJ Kim, JY Kim, AG Senejani, SS Hwang, LK Kim, Z Tobiasova, GR Lee, J Craft, AL Bothwell, JM Choi |
PloS one | 2014 |
Hrd1-mediated BLIMP-1 ubiquitination promotes dendritic cell MHCII expression for CD4 T cell priming during inflammation
H Yang, Q Qiu, B Gao, S Kong, Z Lin, D Fang |
2014 | |
Resveratrol Possesses Protective Effects in a Pristane-Induced Lupus Mouse Model
ZL Wang, XF Luo, MT Li, D Xu, S Zhou, HZ Chen, N Gao, Z Chen, LL Zhang, XF Zeng, C Kanellopoulos-Langevin |
PloS one | 2014 |
Renal Protective Effect of Sirtuin 1
Y Dong, N Liu, Z Xiao, T Sun, S Wu, W Sun, Z Xu, H Yuan |
Journal of Diabetes Research | 2014 |
Stem Cell Treatment for Alzheimer’s Disease
M Li, K Guo, S Ikehara |
International journal of molecular sciences | 2014 |